Fernandez-Cuesta L, Alcala N, Mathian E, Derks J, Thirlwell C, Dayton T
J Clin Invest. 2025; 135(5).
PMID: 40026252
PMC: 11870734.
DOI: 10.1172/JCI186702.
Bencivenga D, Stampone E, Azhar J, Parente D, Ali W, Del Vecchio V
Cells. 2025; 14(3).
PMID: 39936980
PMC: 11817124.
DOI: 10.3390/cells14030188.
Ear P, Marinoni I, Dayton T, Guenter R, Quelle D, Battistella A
Endocr Oncol. 2025; 4(1):e240055.
PMID: 39822778
PMC: 11737514.
DOI: 10.1530/EO-24-0055.
Tatyana F, Avsievich E, Salimgereeva D, Antysheva Z, Maluchenko A, Maksimov D
J Cancer Res Clin Oncol. 2024; 151(1):28.
PMID: 39738894
PMC: 11688255.
DOI: 10.1007/s00432-024-06071-z.
Liu J, Ling J, Li L, Wu Y, Song C, Shi S
Abdom Radiol (NY). 2024; .
PMID: 39694946
DOI: 10.1007/s00261-024-04764-0.
Multifaceted modeling of small intestinal neuroendocrine tumors.
Andrews S, Forsythe S, Madigan J, Sadowski S
Endocr Oncol. 2024; 4(1):e240038.
PMID: 39649120
PMC: 11623265.
DOI: 10.1530/EO-24-0038.
Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors.
Fields B, Ayabe R, Seo Y, Maxwell J, Halperin D
Curr Oncol Rep. 2024; 26(11):1530-1542.
PMID: 39466478
PMC: 11776107.
DOI: 10.1007/s11912-024-01610-w.
Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment.
Tan B, Zhang B, Chen H
Front Endocrinol (Lausanne). 2024; 15:1424839.
PMID: 39411312
PMC: 11474919.
DOI: 10.3389/fendo.2024.1424839.
The University of Iowa Neuroendocrine Tumor Clinic.
Howe J, Menda Y, Chandrasekharan C, Bellizzi A, Quelle D, ODorisio M
Endocr Pract. 2024; 31(1):4-18.
PMID: 39349242
PMC: 11700786.
DOI: 10.1016/j.eprac.2024.09.018.
A Comprehensive Overview of NF1 Mutations in Iranian Patients.
Savad S, Modarressi M, Younesi S, Seifi-Alan M, Samadaian N, Masoomy M
Neuromolecular Med. 2024; 26(1):28.
PMID: 38954284
DOI: 10.1007/s12017-024-08790-5.
Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives.
Zhang X, Fan Y, Jing R, Getu M, Chen W, Zhang W
Mil Med Res. 2024; 11(1):35.
PMID: 38835066
PMC: 11149301.
DOI: 10.1186/s40779-024-00535-6.
Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?.
Uccella S
Endocr Pathol. 2024; 35(2):91-106.
PMID: 38470548
PMC: 11176254.
DOI: 10.1007/s12022-024-09807-2.
HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S, Wang J, Cui Z, Yang X, Cui X, Li X
Sci Rep. 2024; 14(1):3870.
PMID: 38365849
PMC: 10873328.
DOI: 10.1038/s41598-024-53854-y.
The Molecular Biology of Midgut Neuroendocrine Neoplasms.
Webster A, Thirlwell C
Endocr Rev. 2023; 45(3):343-350.
PMID: 38123518
PMC: 11074790.
DOI: 10.1210/endrev/bnad034.
Multiomic sequencing of paired primary and metastatic small bowel carcinoids.
Postel M, Darabi S, Howe J, Liang W, Craig D, Demeure M
F1000Res. 2023; 12:417.
PMID: 37954063
PMC: 10632590.
DOI: 10.12688/f1000research.130251.2.
Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome.
Ruggeri R, Benevento E, De Cicco F, Grossrubatscher E, Hasballa I, Tarsitano M
Endocrine. 2023; 82(3):480-490.
PMID: 37632635
DOI: 10.1007/s12020-023-03497-2.
Long-term organoid culture of a small intestinal neuroendocrine tumor.
DAgosto S, Fiorini E, Pezzini F, Delfino P, Simbolo M, Vicentini C
Front Endocrinol (Lausanne). 2023; 14:999792.
PMID: 37082125
PMC: 10112019.
DOI: 10.3389/fendo.2023.999792.
Neuroendocrine Neoplasms of the Gastrointestinal Tract versus Neuroendocrine Neoplasms of the Gynaecological Tract-Comparison of the Risk Factors and Non-Surgical Treatment Efficacy.
Lorenz A, Lenkiewicz S, Kozlowski M, Kwiatkowski S, Cymbaluk-Ploska A
Int J Mol Sci. 2023; 24(7).
PMID: 37047829
PMC: 10095130.
DOI: 10.3390/ijms24076853.
Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms.
Reccia I, Pai M, Kumar J, Spalding D, Frilling A
Cancers (Basel). 2023; 15(6).
PMID: 36980746
PMC: 10047148.
DOI: 10.3390/cancers15061861.
Molecular and Clinical Spectrum of Primary Hyperparathyroidism.
Jha S, Simonds W
Endocr Rev. 2023; 44(5):779-818.
PMID: 36961765
PMC: 10502601.
DOI: 10.1210/endrev/bnad009.